Clinico-biological trajectories stratified by combined tau biomarkers in preclinical Alzheimer's disease. | ClinicLens
Tau pathology biomarkers provide prognostic indicators of neurodegeneration and cognitive decline in Alzheimer's disease (AD), making them crucial to early patient stratification for disease-modifying interventions. Plasma p-tau217 indexes early tau pathophysiology, whereas
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.